nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Leukoderma—Didanosine—acquired immunodeficiency syndrome	0.0699	0.0954	CcSEcCtD
Flurandrenolide—SERPINA6—blood plasma—acquired immunodeficiency syndrome	0.0475	0.178	CbGeAlD
Flurandrenolide—Folliculitis—Nelfinavir—acquired immunodeficiency syndrome	0.0412	0.0562	CcSEcCtD
Flurandrenolide—Folliculitis—Indinavir—acquired immunodeficiency syndrome	0.0332	0.0453	CcSEcCtD
Flurandrenolide—Eruption—Efavirenz—acquired immunodeficiency syndrome	0.0321	0.0437	CcSEcCtD
Flurandrenolide—Folliculitis—Efavirenz—acquired immunodeficiency syndrome	0.0314	0.0428	CcSEcCtD
Flurandrenolide—Folliculitis—Delavirdine—acquired immunodeficiency syndrome	0.03	0.041	CcSEcCtD
Flurandrenolide—Folliculitis—Ritonavir—acquired immunodeficiency syndrome	0.0278	0.0379	CcSEcCtD
Flurandrenolide—NR3C1—nerve—acquired immunodeficiency syndrome	0.0275	0.103	CbGeAlD
Flurandrenolide—Folliculitis—Saquinavir—acquired immunodeficiency syndrome	0.0267	0.0364	CcSEcCtD
Flurandrenolide—Folliculitis—Lamivudine—acquired immunodeficiency syndrome	0.0255	0.0348	CcSEcCtD
Flurandrenolide—Skin discolouration—Zidovudine—acquired immunodeficiency syndrome	0.0248	0.0339	CcSEcCtD
Flurandrenolide—Skin discolouration—Efavirenz—acquired immunodeficiency syndrome	0.0218	0.0298	CcSEcCtD
Flurandrenolide—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.0208	0.0778	CbGeAlD
Flurandrenolide—Dermatitis contact—Indinavir—acquired immunodeficiency syndrome	0.0206	0.0281	CcSEcCtD
Flurandrenolide—Skin discolouration—Ritonavir—acquired immunodeficiency syndrome	0.0193	0.0264	CcSEcCtD
Flurandrenolide—SERPINA6—blood—acquired immunodeficiency syndrome	0.0174	0.0651	CbGeAlD
Flurandrenolide—Dermatitis contact—Ritonavir—acquired immunodeficiency syndrome	0.0172	0.0235	CcSEcCtD
Flurandrenolide—SERPINA6—bone marrow—acquired immunodeficiency syndrome	0.0168	0.063	CbGeAlD
Flurandrenolide—SERPINA6—lung—acquired immunodeficiency syndrome	0.0152	0.057	CbGeAlD
Flurandrenolide—SERPINA6—nervous system—acquired immunodeficiency syndrome	0.0141	0.0528	CbGeAlD
Flurandrenolide—SERPINA6—central nervous system—acquired immunodeficiency syndrome	0.0136	0.0509	CbGeAlD
Flurandrenolide—SERPINA6—brain—acquired immunodeficiency syndrome	0.0108	0.0404	CbGeAlD
Flurandrenolide—Infection—Didanosine—acquired immunodeficiency syndrome	0.0105	0.0144	CcSEcCtD
Flurandrenolide—NR3C1—skin of body—acquired immunodeficiency syndrome	0.00999	0.0374	CbGeAlD
Flurandrenolide—Infection—Abacavir—acquired immunodeficiency syndrome	0.00901	0.0123	CcSEcCtD
Flurandrenolide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00823	0.0112	CcSEcCtD
Flurandrenolide—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.00809	0.0303	CbGeAlD
Flurandrenolide—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00799	0.0299	CbGeAlD
Flurandrenolide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00782	0.0107	CcSEcCtD
Flurandrenolide—NR3C1—blood—acquired immunodeficiency syndrome	0.00761	0.0285	CbGeAlD
Flurandrenolide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00751	0.0102	CcSEcCtD
Flurandrenolide—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.00737	0.0276	CbGeAlD
Flurandrenolide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00734	0.01	CcSEcCtD
Flurandrenolide—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.00734	0.0275	CbGeAlD
Flurandrenolide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00733	0.01	CcSEcCtD
Flurandrenolide—NR3C1—vagina—acquired immunodeficiency syndrome	0.00706	0.0264	CbGeAlD
Flurandrenolide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00703	0.00959	CcSEcCtD
Flurandrenolide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00681	0.00929	CcSEcCtD
Flurandrenolide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00679	0.00926	CcSEcCtD
Flurandrenolide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00675	0.00921	CcSEcCtD
Flurandrenolide—Rash—Didanosine—acquired immunodeficiency syndrome	0.00669	0.00913	CcSEcCtD
Flurandrenolide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00669	0.00912	CcSEcCtD
Flurandrenolide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00668	0.00912	CcSEcCtD
Flurandrenolide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00668	0.00912	CcSEcCtD
Flurandrenolide—NR3C1—lung—acquired immunodeficiency syndrome	0.00667	0.025	CbGeAlD
Flurandrenolide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00654	0.00892	CcSEcCtD
Flurandrenolide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00652	0.00889	CcSEcCtD
Flurandrenolide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00642	0.00876	CcSEcCtD
Flurandrenolide—NR3C1—nervous system—acquired immunodeficiency syndrome	0.00618	0.0231	CbGeAlD
Flurandrenolide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00601	0.00821	CcSEcCtD
Flurandrenolide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00601	0.0082	CcSEcCtD
Flurandrenolide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00595	0.00812	CcSEcCtD
Flurandrenolide—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.00595	0.0223	CbGeAlD
Flurandrenolide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00582	0.00795	CcSEcCtD
Flurandrenolide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00582	0.00794	CcSEcCtD
Flurandrenolide—Rash—Stavudine—acquired immunodeficiency syndrome	0.00581	0.00792	CcSEcCtD
Flurandrenolide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0058	0.00792	CcSEcCtD
Flurandrenolide—Rash—Abacavir—acquired immunodeficiency syndrome	0.00572	0.00781	CcSEcCtD
Flurandrenolide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00572	0.0078	CcSEcCtD
Flurandrenolide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00568	0.00775	CcSEcCtD
Flurandrenolide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00566	0.00773	CcSEcCtD
Flurandrenolide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00548	0.00748	CcSEcCtD
Flurandrenolide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00527	0.00719	CcSEcCtD
Flurandrenolide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00518	0.00707	CcSEcCtD
Flurandrenolide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00505	0.00689	CcSEcCtD
Flurandrenolide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00504	0.00688	CcSEcCtD
Flurandrenolide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00498	0.00679	CcSEcCtD
Flurandrenolide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00496	0.00677	CcSEcCtD
Flurandrenolide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00476	0.0065	CcSEcCtD
Flurandrenolide—NR3C1—brain—acquired immunodeficiency syndrome	0.00472	0.0177	CbGeAlD
Flurandrenolide—Rash—Indinavir—acquired immunodeficiency syndrome	0.00469	0.00641	CcSEcCtD
Flurandrenolide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00469	0.0064	CcSEcCtD
Flurandrenolide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00459	0.00626	CcSEcCtD
Flurandrenolide—NR3C1—lymph node—acquired immunodeficiency syndrome	0.00456	0.0171	CbGeAlD
Flurandrenolide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00443	0.00605	CcSEcCtD
Flurandrenolide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00443	0.00605	CcSEcCtD
Flurandrenolide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00441	0.00602	CcSEcCtD
Flurandrenolide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.0044	0.00601	CcSEcCtD
Flurandrenolide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00424	0.00579	CcSEcCtD
Flurandrenolide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00424	0.00578	CcSEcCtD
Flurandrenolide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00424	0.00578	CcSEcCtD
Flurandrenolide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00421	0.00574	CcSEcCtD
Flurandrenolide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00404	0.00552	CcSEcCtD
Flurandrenolide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00535	CcSEcCtD
Flurandrenolide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00535	CcSEcCtD
Flurandrenolide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00378	0.00515	CcSEcCtD
Flurandrenolide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00377	0.00515	CcSEcCtD
Flurandrenolide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.0036	0.00492	CcSEcCtD
Flurandrenolide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.0036	0.00491	CcSEcCtD
